Htii-280 Alveolar Cells

HTII-280 labeling relies on an antibody that recognizes a cell-surface antigen associated with human alveolar type II epithelial cells. Because the target is exposed at the cell surface, labeled cells can be detected during flow cytometry and selected for enrichment with related cell-separation approaches. This provides a practical way to obtain a more defined population for downstream lung studies.

Recognition of a cell-surface antigen connects identification with physical cell separation. Researchers can distinguish the HTII-280-positive population during flow-based analysis and enrich it for subsequent experiments, rather than relying only on observations made after culture. That separation supports more focused investigations of alveolar epithelial behavior, including surfactant production, repair-associated changes, and responses in experimental models.

Under appropriate culture conditions, the enriched cells can produce pulmonary surfactant and acquire features associated with alveolar type I cells. These changes are useful because they connect marker-based enrichment with functional and phenotypic analysis. Researchers can therefore examine both the maintenance of type II cell characteristics and the emergence of properties relevant to the lung gas-exchange surface.

A typical workflow begins by labeling a cell preparation with the HTII-280 antibody, followed by detection and enrichment through flow cytometry or a related separation method. The selected population is then placed under appropriate culture conditions and evaluated for features such as surfactant production or acquisition of type I cell characteristics. This sequence links identification, enrichment, culture, and outcome measurement.

Researchers can assess whether cultured cells produce pulmonary surfactant or develop features associated with alveolar type I cells. These outcomes help evaluate epithelial state and changes relevant to maintenance or repair of the gas-exchange surface. The same enriched population can also serve as a biological starting point for examining lung development, regeneration, disease-related behavior, or experimental treatments.

Their value comes from combining a defined enrichment strategy with experimental relevance to human respiratory biology. Investigators use them to study lung development and epithelial regeneration, build organoid models, investigate pulmonary disease, and examine responses to drugs or injury. These applications make the cells useful for connecting cellular behavior with disease mechanisms and potential translational models.